RINVOQ

Results Results Results

For adults with active psoriatic arthritis (PsA) in whom TNF blockers did not work well.

Proven in clinical studies for PsA, RINVOQ can:

Illustration of joint pain at the knee

Significantly relieve joint pain, swelling, and stiffness

Illustration of a psoriatic arthritis skin plaque

Leave skin* noticeably clearer for people with skin plaques

Illustration of painful joint damage

Stop further irreversible joint damage

Illustration of a battery low on power

Significantly reduce PsA fatigue

*RINVOQ is not approved to treat plaque psoriasis.

Scroll to see more RINVOQ results

Safety Considerations

RINVOQ may cause serious side effects, including:

  • Serious infections. RINVOQ can lower ability to fight infections. Serious infections, some fatal, occurred, including tuberculosis (TB) and infections caused by bacteria, fungi, or viruses.
  • Increased risk of death in people age 50+ with at least 1 heart disease risk factor.
  • Cancer and immune system problems. Increased risk of some cancers, including lymphoma and skin. Current or past smokers have higher risk for lymphoma and lung cancer.
  • Increased risk of major cardiovascular events such as heart attack, stroke, or death in people 50+ with at least 1 heart disease risk factor, especially in current or past smokers.
  • Blood clots, some fatal, in veins of the legs or lungs and arteries. This occurred more often in people 50+ with at least 1 heart disease risk factor.
  • Serious allergic reactions. Do not take if allergic to RINVOQ or its ingredients.
  • Tears in the stomach or intestines; changes in certain laboratory test results.

Learn more about these and the full Important Safety Information below.

Fast relief that can last

In a clinical study, RINVOQ helped relieve PsA joint pain, swelling, and stiffness for some people in as little as 2 weeks. The majority of people taking RINVOQ had significantly improved symptoms at 12 weeks.

A similar percentage of people reported relief over a year later (at 56 weeks).

Helps relieve PsA pain, swelling, and stiffness in 2 weeks, 12 weeks, and 56 weeks.

Individual results may vary.

Relief at 3 years (152 weeks)

Of those who continued taking RINVOQ for 3 years, many saw improvement in PsA symptoms. In this less rigorous part of the study, patients and physicians were aware of RINVOQ treatment, which may have influenced these results at 3 years.

20% improvement in PsA symptoms when used with or without csDMARDs. Doctors adjusted supportive PsA medicines as needed at week 16 or 36.

PsA skin clearance before and after

In a clinical trial, the majority of people achieved 75% skin* clearance at 4 months.

Drag the slider below to see results.

Illustration of PsA skin plaques on an elbow after treatment

After 4 months

Before

Illustration of PsA skin plaques on an elbow before treatment

Illustration of skin clearance for people with moderate to severe PsA skin plaques. Individual results may vary.

Illustration of PsA skin plaques on a knee after treatment

After 4 months

Before

Illustration of PsA skin plaques on a knee before treatment

Illustration of skin clearance for people with moderate to severe PsA skin plaques. Individual results may vary.

RINVOQ has not been studied in and is not indicated for the treatment of plaque psoriasis.

Understanding the possible side effects of RINVOQ

Consider the benefits and risks of taking RINVOQ to make an informed treatment choice with your rheumatologist.

Which best describes how you feel about your current PsA treatment plan?

It’s important to regularly monitor your PsA symptoms and work with your doctor to evaluate your treatment plan.
Partner With a Rheumatologist >

If you’re unsatisfied with your current treatment plan—talk to your rheumatologist about other treatment options to help get your PsA symptoms under control. Partner With a Rheumatologist >

A rheumatologist can evaluate your PsA symptoms and help create a treatment plan that meets your unique needs. Find a Rheumatologist >

More RINVOQ results

RINVOQ can help people achieve Minimal Disease Activity—that can mean less joint pain, swelling, stiffness, and skin* symptoms

*RINVOQ is not approved to treat plaque psoriasis.

RINVOQ CAN ALSO:

  • Make it easier to do everyday things
  • Relieve tenderness for people with enthesitis (pain and swelling in areas like the heel and elbow)
  • Reduce swelling of fingers and toes for people with dactylitis (also called “sausage fingers”)
Illustration of two hands shaking

A rheumatologist can help keep you on track

Your response to treatment can change over time, so learning about PsA treatment options can help you make informed decisions with your rheumatologist.

Be fierce Be fierce Be fierce

Are you planning on visiting a rheumatologist within the next 60 days?

Preparing for your rheumatologist visit can help you make the most of your time together. The Appointment Checklist can help you discuss symptoms, challenges, goals and more. Start the Appointment Checklist now >

If you're still having PsA symptoms, make a rheumatologist appointment as soon as possible and let them know how your symptoms are affecting you. They can help you treat your PsA and reach your treatment goals. Find a rheumatologist >

If you're still having PsA symptoms, make a rheumatologist appointment as soon as possible and let them know how your symptoms are affecting you. They can help you treat your PsA and reach your treatment goals. Find a rheumatologist >

What that means for you

RINVOQ helps fight PsA joint pain, swelling, stiffness, skin* symptoms, and PsA fatigue in a once-daily pill. But to see if RINVOQ can be a part of your treatment plan, you first have to ask your rheumatologist.

Illustration of a book with two quotations

Share your
RINVOQ story

Share your experience with RINVOQ to help inform and inspire others. To participate, please email us at info@SPEAKnetwork.net or call 877-861-6180.

NEXT PAGE